Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Treatment of Some Men With Non-Obstructive Azoospermia
NCT06706414Phase 2Completed
- Start
- Mar 2025
- Primary completion
- Apr 2026
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in nonobstructive azoospermia (NOA). Started Mar 2025; status: completed.
02
Drugs
denosumab
03
Conditions
nonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on NCT06706414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706414.